{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:00:22Z","timestamp":1792789222354,"version":"4.5.0"},"reference-count":62,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:00:00Z","timestamp":1567036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004418","name":"Vrije Universiteit Brussel","doi-asserted-by":"publisher","award":["\/"],"award-info":[{"award-number":["\/"]}],"id":[{"id":"10.13039\/501100004418","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003132","name":"Agentschap voor Innovatie door Wetenschap en Technologie","doi-asserted-by":"publisher","award":["HILIM-3D; SBO140045"],"award-info":[{"award-number":["HILIM-3D; SBO140045"]}],"id":[{"id":"10.13039\/501100003132","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gilead Sciences BeLux Fellowship Programme 2018","award":["\/"],"award-info":[{"award-number":["\/"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Background: The current diagnosis of early-stage liver fibrosis often relies on a serological or imaging-based evaluation of the stage of fibrosis, sometimes followed by an invasive liver biopsy procedure. Novel non-invasive experimental diagnostic tools are often based on markers of hepatocyte damage, or changes in liver stiffness and architecture, which are late-stage characteristics of fibrosis progression, making them unsuitable for the diagnosis of early-stage liver fibrosis. miRNAs control hepatic stellate cell (HSC) activation and are proposed as relevant diagnostic markers. Methods: We investigated the possibility of circulating miRNAs, which we found to be dysregulated upon HSC activation, to mark the presence of significant liver fibrosis (F \u2265 2) in patients with chronic alcohol abuse, chronic viral infection (HBV\/HCV), and non-alcoholic fatty liver disease (NAFLD). Results: miRNA-profiling identified miRNA-451a, miRNA-142-5p, Let-7f-5p, and miRNA-378a-3p to be significantly dysregulated upon in vitro HSC activation, and to be highly enriched in their extracellular vesicles, suggesting their potential use as biomarkers. Analysis of the plasma of patients with significant liver fibrosis (F \u2265 2) and no or mild fibrosis (F = 0\u20131), using miRNA-122-5p and miRNA-29a-3p as positive control, found miRNA-451a, miRNA-142-5p, and Let-7f-5p, but not miRNA-378a-3p, able to distinguish between the two patient populations. Using logistic regression analysis, combining all five dysregulated circulating miRNAs, we created the miRFIB-score with a predictive value superior to the clinical scores Fibrosis-4 (Fib-4), aspartate aminotransferase\/alanine aminotransferase (AST\/ALT) ratio, and AST to platelet ratio index (APRI). The combination of the miRFIB-score with circulating PDGFR\u03b2-levels further increased the predictive capacity for the diagnosis of significant liver fibrosis. Conclusions: The miRFIB- and miRFIBp-scores are accurate tools for the diagnosis of significant liver fibrosis in a heterogeneous patient population.<\/jats:p>","DOI":"10.3390\/cells8091003","type":"journal-article","created":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T11:26:22Z","timestamp":1567077982000},"page":"1003","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["The miRFIB-Score: A Serological miRNA-Based Scoring Algorithm for the Diagnosis of Significant Liver Fibrosis"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6202-4874","authenticated-orcid":false,"given":"Joeri","family":"Lambrecht","sequence":"first","affiliation":[{"name":"Department of Basic (Bio-)Medical Sciences, Liver Cell Biology Research Group, Vrije Universiteit Brussel, 1050 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefaan","family":"Verhulst","sequence":"additional","affiliation":[{"name":"Department of Basic (Bio-)Medical Sciences, Liver Cell Biology Research Group, Vrije Universiteit Brussel, 1050 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2701-5777","authenticated-orcid":false,"given":"Hendrik","family":"Reynaert","sequence":"additional","affiliation":[{"name":"Department of Basic (Bio-)Medical Sciences, Liver Cell Biology Research Group, Vrije Universiteit Brussel, 1050 Brussels, Belgium"},{"name":"Department of Gastroenterology and Hepatology, University Hospital Brussels (UZ Brussel), B-1090 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo A.","family":"van Grunsven","sequence":"additional","affiliation":[{"name":"Department of Basic (Bio-)Medical Sciences, Liver Cell Biology Research Group, Vrije Universiteit Brussel, 1050 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,8,29]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2019, July 11). Global Health Estimates for Cause Specific Mortality. Available online: https:\/\/www.who.int\/healthinfo\/global_burden_disease\/estimates\/en\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","article-title":"Liver cirrhosis","volume":"383","author":"Tsochatzis","year":"2014","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","article-title":"Pathobiology of liver fibrosis: A translational success story","volume":"64","author":"Lee","year":"2015","journal-title":"Gut"},{"key":"ref_5","first-page":"737","article-title":"Reversibility of liver fibrosis","volume":"9","author":"Brenner","year":"2013","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1111\/j.1572-0241.2002.06038.x","article-title":"Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection","volume":"97","author":"Regev","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/hep.510270506","article-title":"Cost-effectiveness of ultrasound-guided liver biopsy","volume":"27","author":"Pasha","year":"1998","journal-title":"Hepatology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/jhep.2000.16602","article-title":"Practices of liver biopsy in France: Results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF)","volume":"32","author":"Cadranel","year":"2000","journal-title":"Hepatology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.bbadis.2018.01.009","article-title":"Prospects in non-invasive assessment of liver fibrosis: Liquid biopsy as the future gold standard?","volume":"1864","author":"Lambrecht","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3389\/fphys.2015.00209","article-title":"The role of miRNAs in stress-responsive hepatic stellate cells during liver fibrosis","volume":"6","author":"Lambrecht","year":"2015","journal-title":"Front. Physiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.tibs.2012.08.003","article-title":"Extracellular miRNAs: The mystery of their origin and function","volume":"37","author":"Turchinovich","year":"2012","journal-title":"Trends Biochem. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"586","DOI":"10.4254\/wjh.v9.i12.586","article-title":"Role of circulating microRNAs in liver diseases","volume":"9","author":"Loosen","year":"2017","journal-title":"World J. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Hayes, C.N., and Chayama, K. (2016). MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17030280"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fphar.2017.00056","article-title":"Circulating ECV-Associated miRNAs as Potential Clinical Biomarkers in Early Stage HBV and HCV Induced Liver Fibrosis","volume":"8","author":"Lambrecht","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jhep.2009.12.007","article-title":"Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells","volume":"52","author":"Guimaraes","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1053\/j.gastro.2008.01.034","article-title":"Performance of transient elastography for the staging of liver fibrosis: A meta-analysis","volume":"134","author":"Ong","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ebiom.2019.04.036","article-title":"A PDGFRbeta-based score predicts significant liver fibrosis in patients with chronic alcohol abuse, NAFLD and viral liver disease","volume":"43","author":"Lambrecht","year":"2019","journal-title":"EBioMedicine"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Seger, S., Stritt, M., Vezzali, E., Nayler, O., Hess, P., Groenen, P.M.A., and Stalder, A.K. (2018). A fully automated image analysis method to quantify lung fibrosis in the bleomycin-induced rat model. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0193057"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/0023677215571192","article-title":"The carbon tetrachloride model in mice","volume":"49","author":"Scholten","year":"2015","journal-title":"Laboratory Animals"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jhep.2012.11.011","article-title":"miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression","volume":"58","author":"Li","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.23922","article-title":"Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis","volume":"53","author":"Roderburg","year":"2011","journal-title":"Hepatology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/hep.24642","article-title":"Where are we in the search for noninvasive nonalcoholic steatohepatitis biomarkers?","volume":"54","author":"Mato","year":"2011","journal-title":"Hepatology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2015.11.012","article-title":"Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients","volume":"64","author":"Kim","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/hep.27382","article-title":"Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: A systemic review and meta-analysis","volume":"61","author":"Xiao","year":"2015","journal-title":"Hepatology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/apt.14517","article-title":"Editorial: Looking for patients at risk of cirrhosis in the general population-many needles in a haystack","volume":"47","author":"Ampuero","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.biocel.2015.04.016","article-title":"Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK\/AKT pathway","volume":"64","author":"Hur","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cca.2013.05.021","article-title":"Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver","volume":"424","author":"Yamada","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"15026","DOI":"10.1038\/srep15026","article-title":"MicroRNA panels as disease biomarkers distinguishing hepatitis B virus infection caused hepatitis and liver cirrhosis","volume":"5","author":"Jin","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"8523","DOI":"10.1038\/ncomms9523","article-title":"miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program","volume":"6","author":"Su","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11684-015-0409-8","article-title":"MicroRNA-142-3p and microRNA-142-5p are downregulated in hepatocellular carcinoma and exhibit synergistic effects on cell motility","volume":"9","author":"Tsang","year":"2015","journal-title":"Front. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/hep.28660","article-title":"Circulating let-7 levels in plasma and extracellular vesicles correlate with hepatic fibrosis progression in chronic hepatitis C","volume":"64","author":"Matsuura","year":"2016","journal-title":"Hepatology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jhep.2016.05.048","article-title":"miR-122 expression is not regulated during activation of hepatic stellate cells","volume":"65","author":"Schueller","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmet.2006.01.005","article-title":"miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting","volume":"3","author":"Esau","year":"2006","journal-title":"Cell Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jhep.2012.10.015","article-title":"Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis","volume":"58","author":"Trebicka","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_38","first-page":"1919","article-title":"Plasma microRNA: A novel non-invasive biomarker for HBV-associated liver fibrosis staging","volume":"17","author":"Wang","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.lfs.2018.07.029","article-title":"Plasma miR-17, miR-20a, miR-20b and miR-122 as potential biomarkers for diagnosis of NAFLD in type 2 diabetes mellitus patients","volume":"208","author":"Ye","year":"2018","journal-title":"Life Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/jvh.12696","article-title":"Serum microRNAs as predictors for liver fibrosis staging in hepatitis C virus-associated chronic liver disease patients","volume":"24","author":"Shaker","year":"2017","journal-title":"J. Viral. Hepat."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1111\/liv.12429","article-title":"Significance of serum and hepatic microRNA-122 levels in patients with non-alcoholic fatty liver disease","volume":"34","author":"Miyaaki","year":"2014","journal-title":"Liver Int."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Waidmann, O., Koberle, V., Brunner, F., Zeuzem, S., Piiper, A., and Kronenberger, B. (2012). Serum microRNA-122 predicts survival in patients with liver cirrhosis. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0045652"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1373\/clinchem.2010.147850","article-title":"Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases","volume":"56","author":"Zhang","year":"2010","journal-title":"Clin. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Yang, Y.L., Wang, F.S., Li, S.C., Tiao, M.M., and Huang, Y.H. (2017). MicroRNA-29a Alleviates Bile Duct Ligation Exacerbation of Hepatic Fibrosis in Mice through Epigenetic Control of Methyltransferases. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18010192"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"212","DOI":"10.7150\/ijms.29930","article-title":"MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation","volume":"16","author":"Huang","year":"2019","journal-title":"Int. J. Med. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Yang, Y.L., Kuo, H.C., Wang, F.S., and Huang, Y.H. (2019). MicroRNA-29a Disrupts DNMT3b to Ameliorate Diet-Induced Non-Alcoholic Steatohepatitis in Mice. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061499"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Li, S.C., Wang, F.S., Yang, Y.L., Tiao, M.M., Chuang, J.H., and Huang, Y.H. (2016). Microarray Study of Pathway Analysis Expression Profile Associated with MicroRNA-29a with Regard to Murine Cholestatic Liver Injuries. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17030324"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/2211536607666180531093302","article-title":"Serum miR-29a and miR-122 as Potential Biomarkers for Non-Alcoholic Fatty Liver Disease (NAFLD)","volume":"7","author":"Jampoka","year":"2018","journal-title":"Microrna"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"860","DOI":"10.5009\/gnl16560","article-title":"Serum MicroRNA Levels as a Noninvasive Diagnostic Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Liver Fibrosis","volume":"11","author":"Bao","year":"2017","journal-title":"Gut Liver"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41580-018-0045-7","article-title":"Regulation of microRNA function in animals","volume":"20","author":"Gebert","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1755-8794-2-5","article-title":"Gene expression profile analysis of human hepatocellular carcinoma using SAGE and LongSAGE","volume":"2","author":"Dong","year":"2009","journal-title":"BMC Med. Genomics"},{"key":"ref_52","first-page":"3043","article-title":"Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1","volume":"63","author":"Okabe","year":"2003","journal-title":"Cancer Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1158\/0008-5472.CAN-05-1553","article-title":"PEG10 is a c-MYC target gene in cancer cells","volume":"66","author":"Li","year":"2006","journal-title":"Cancer Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.canlet.2006.10.012","article-title":"Identification of PEG10 as a progression related biomarker for hepatocellular carcinoma","volume":"250","author":"Ip","year":"2007","journal-title":"Cancer Lett."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"844","DOI":"10.4143\/crt.2014.124","article-title":"Expression of PEG10 Is Associated with Poor Survival and Tumor Recurrence in Hepatocellular Carcinoma","volume":"47","author":"Bang","year":"2015","journal-title":"Cancer Res. Treat."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"266","DOI":"10.18632\/oncotarget.5689","article-title":"MicroRNA-107: A novel promoter of tumor progression that targets the CPEB3\/EGFR axis in human hepatocellular carcinoma","volume":"7","author":"Zou","year":"2016","journal-title":"Oncotarget"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1177\/1533034617735931","article-title":"Mir-452-3p: A Potential Tumor Promoter That Targets the CPEB3\/EGFR Axis in Human Hepatocellular Carcinoma","volume":"16","author":"Tang","year":"2017","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.canlet.2014.11.013","article-title":"GNAI3 inhibits tumor cell migration and invasion and is post-transcriptionally regulated by miR-222 in hepatocellular carcinoma","volume":"356","author":"Zhang","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1158\/1940-6207.CAPR-11-0370","article-title":"Blood cell origin of circulating microRNAs: A cautionary note for cancer biomarker studies","volume":"5","author":"Pritchard","year":"2012","journal-title":"Cancer Prev. Res."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Kirschner, M.B., Kao, S.C., Edelman, J.J., Armstrong, N.J., Vallely, M.P., van Zandwijk, N., and Reid, G. (2011). Haemolysis during sample preparation alters microRNA content of plasma. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0024145"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Koberle, V., Pleli, T., Schmithals, C., Augusto Alonso, E., Haupenthal, J., Bonig, H., Peveling-Oberhag, J., Biondi, R.M., Zeuzem, S., and Kronenberger, B. (2013). Differential stability of cell-free circulating microRNAs: Implications for their utilization as biomarkers. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0075184"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"34935","DOI":"10.1038\/srep34935","article-title":"MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C","volume":"6","author":"Appourchaux","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/8\/9\/1003\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:15:05Z","timestamp":1760188505000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/8\/9\/1003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,29]]},"references-count":62,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9]]}},"alternative-id":["cells8091003"],"URL":"https:\/\/doi.org\/10.3390\/cells8091003","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,29]]}}}